Analytical Data
-
基因名
Afamin/AFM
- Application
-
别名
ALB2; ALBA; ALF; A-ALB; Alpha-Albumin
-
种属
Mouse
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 95% as determined by SDS-PAGE.
-
蛋白编号
O89020
-
表达区间
Thr210~Glu403
-
分子量
23kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Afamin (AFM) is a member of the albumin family of proteins, primarily found in the bloodstream where it plays a crucial role in transporting vitamin E and other lipophilic molecules. Research on Afamin has gained traction due to its potential implications in various physiological and pathological processes, including cardiovascular health, metabolic disorders, and even cancer. Recent studies have shown that Afamin levels may serve as biomarkers for certain diseases, and its dysregulation is associated with conditions such as diabetes and atherosclerosis. The recombinant production of Afamin protein offers a promising avenue for exploring its biological functions and the mechanisms underlying its association with disease states. By utilizing recombinant DNA technology, researchers can generate large quantities of Afamin to study its structure, function, and interactions with other molecules in detail. This has paved the way for potential therapeutic applications, where recombinant Afamin could be used in treatments that target vitamin E deficiency or related metabolic dysfunctions. Furthermore, understanding the precise role of Afamin can contribute to the development of novel diagnostic tools, enhancing our ability to predict and monitor disease progression. Overall, ongoing research into recombinant Afamin not only deepens our understanding of this protein's significance but also highlights its potential as a biomarker and therapeutic agent in modern medicine.












